BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14233801)

  • 1. TWENTY YEARS AFTERWARD HISTORICAL NOTES ON THE DISCOVERY OF THE ANTITUBERCULOSIS EFFECT OF PARAAMINOSALICYLIC ACID (PAS) AND THE FIRST CLINICAL TRIALS.
    LEHMANN J
    Am Rev Respir Dis; 1964 Dec; 90():953-6. PubMed ID: 14233801
    [No Abstract]   [Full Text] [Related]  

  • 2. A micro-method for the determination of paraaminosalicylic acid (aminosallyl) PAS and n-acetyl-para-aminosalicylic acid (acetyl-PAS).
    NIELSEN E; PRAETORIUS E
    Scand J Clin Lab Invest; 1952; 4(4):313-8. PubMed ID: 13048610
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical pharmacokinetics of para-aminosalicylic acid tablets].
    Miroshnichenko II; Sokolova GB; Mokhireva LV
    Antibiot Khimioter; 2009; 54(1-2):20-4. PubMed ID: 19499713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [VARIATION IN THE PRICE OF PAS PREPARATIONS AND ITS EFFECT ON THE TOTAL EXPENSES OF ANTITUBERCULAR TREATMENT].
    HAAPANEN JH; PIKKOLA E
    Duodecim; 1964; 80():551-3. PubMed ID: 14169996
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of antitubercular agents, especially PAS, on the serum cholesterol level in pulmonary tuberculosis].
    KAGEURA K
    Nagasaki Igakkai Zasshi; 1963 Jan; 38():54-81. PubMed ID: 13958259
    [No Abstract]   [Full Text] [Related]  

  • 6. [EXPERIMENTAL STUDIES ON THE EFFECT OF SO-CALLED SECONDARY ANTITUBERCULOSIS DRUGS. (1). COMBINATION EFFECTS OF SM-INH-PAS, SM-INH-TH AND KM-TH-CS ON EXPERIMENTAL TUBERCULOSIS IN MICE].
    TAGA M
    Kekkaku; 1964 Dec; 39():543-9. PubMed ID: 14270667
    [No Abstract]   [Full Text] [Related]  

  • 7. [SUPPLEMENTARY INFORMATION ON THE ANTITUBERCULAR ACTION OF PAS-PHENYLESTERS].
    MAEKAWA N; TSUKUMA S; SHIMIZU A; KAWAI M; NAKAI J; KUZE F; OZAWA A
    Kyoto Daigaku Kekkaku Kenkyusho Kiyo; 1964 Mar; 12():89-96. PubMed ID: 14161659
    [No Abstract]   [Full Text] [Related]  

  • 8. Pay dirt: the story of streptomycin. Part II. Feldman and Hinshaw; Lehmann.
    Comroe JH
    Am Rev Respir Dis; 1978 May; 117(5):957-68. PubMed ID: 350110
    [No Abstract]   [Full Text] [Related]  

  • 9. [INVESTIGATION OF ANTITUBERCULAR AGENTS. 12. ON THE EFFECT OF PAS-ALKYLESTER AND-ARYLESTER ON THE INHIBITION OF THE GROWTH OF TUBERCLE BACILLUS IN VITRO].
    TSUKUMA S; NAKANISHI M; IKEDA N; NAKAI J; YOSHIWARA N
    Kyoto Daigaku Kekkaku Kenkyusho Kiyo; 1963 Sep; 12():59-64. PubMed ID: 14113186
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE REASON FOR OUR DISAPPOINTMENTS IN THE ANTITUBERCULOSIS CAMPAIGN].
    VIDAL J
    Sem Hop; 1964 Dec; 40():2879-81. PubMed ID: 14256577
    [No Abstract]   [Full Text] [Related]  

  • 11. PRACTICAL METHODS OF DETECTING MAJOR ANTITUBERCULOSIS DRUGS IN THE URINE.
    HOBBY GL
    Bibl Tuberc; 1964; 19():98-120. PubMed ID: 14271078
    [No Abstract]   [Full Text] [Related]  

  • 12. [CURRENT PROBLEMS IN THE ANTITUBERCULOSIS CAMPAIGN].
    ZORZOLI P
    Rass Clin Sci; 1964 May; 40():129-34. PubMed ID: 14166085
    [No Abstract]   [Full Text] [Related]  

  • 13. Brain regional pharmacokinetics of p-aminosalicylic acid and its N-acetylated metabolite: effectiveness in chelating brain manganese.
    Hong L; Jiang W; Pan H; Jiang Y; Zeng S; Zheng W
    Drug Metab Dispos; 2011 Oct; 39(10):1904-9. PubMed ID: 21768272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MYXEDEMA IN THE COURSE OF ANTITUBERCULOSIS THERAPY].
    MARCHESE MJ; BERTORELLO MC; CARDOZO E
    Rev Asoc Med Argent; 1963 Nov; 77():542-4. PubMed ID: 14108781
    [No Abstract]   [Full Text] [Related]  

  • 15. [STUDY OF THE EFFECTIVENESS OF CHEMOTHERAPY OF TUBERCULOSIS ACCORDING TO THE PLAN PROPOSED BY THE INTERNATIONAL ANTITUBERCULOSIS SOCIETY].
    ALIABINA MG; STUKALOVA BI
    Probl Tuberk; 1963; 41():24-8. PubMed ID: 14108757
    [No Abstract]   [Full Text] [Related]  

  • 16. PULMONARY TUBERCULOSIS IN RETROSPECT AND PROSPECT.
    THOMAS CP
    Ann R Coll Surg Engl; 1964 Aug; 35(2):67-83. PubMed ID: 14180407
    [No Abstract]   [Full Text] [Related]  

  • 17. [COMMENTS ON 2 CASES OF SEVERE ALLERGIC REACTION TO SODIUM PARA-AMINOSALICYLATE (PAS)].
    POP E; NICULESCU M; ZAMFIRESCU E; NEGHINA S
    Med Interna (Bucur); 1964 Dec; 16():1493-6. PubMed ID: 14305643
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacokinetics of PAS].
    Khabarov AA; Povaliaeva LI; Novosel'skaia LM
    Farmatsiia; 1977; 26(4):49-50. PubMed ID: 902798
    [No Abstract]   [Full Text] [Related]  

  • 19. ACTIVITY OF ANTITUBERCULOSIS DRUGS AGAINST MYCOBACTERIUM LEPRAE.
    SHEPARD CC; CHANG YT
    Int J Lepr; 1964; 32():260-71. PubMed ID: 14227399
    [No Abstract]   [Full Text] [Related]  

  • 20. [INFORMATION ON A NEW TECHNIQUE FOR ANTITUBERCULOSIS THERAPY].
    CASTELLARIERA J; GRANENAFUGUET P; COLLCOLOME F
    Folia Clin Int (Barc); 1964 Mar; 14():152-60. PubMed ID: 14156917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.